Potentiation of cancer therapies by ZNF217 inhibition
申请人:REGENTS OF THE UNIVERSITY OF CALIFORNIA
公开号:US20040038322A1
公开(公告)日:2004-02-26
This invention provides methods, reagents and kits for treating cancer in a patient or subject, e.g., a human. Accordingly, the present methods can be used to monitor the efficacy of a cancer treatment and to treat cancer, e.g., by inhibiting the expression and/or activity of ZNF217 in a neoplastic cell.
[EN] POTENTIATION OF CANCER THERAPIES BY ZNF217 INHIBITION<br/>[FR] RENFORCEMENT DE THERAPIES CANCEREUSES PAR INHIBITION DE ZNF217
申请人:UNIV CALIFORNIA
公开号:WO2003079748A2
公开(公告)日:2003-10-02
This invention provides methods, reagents and kits for treating cancer in a patient or subject, e.g., a human. Accordingly, the present methods can be used to monitor the efficacy of a cancer treatment and to treat cancer, e.g., by inhibiting the expression and/or activity of ZNF217 in a neoplastic cell.
Products of the condensation reaction of 2-(4-fluorobenzoyl)benzoic acid with m-cresol
作者:J. Gronowska、A. Kalinowska
DOI:10.1016/s0022-1139(00)80107-4
日期:1993.4
The preparation and structural elucidation of the new isomeric 3-(4-fluorophenyl)-3-(hydroxymethyl)phthalidesmade from m-cresol and 2-(4-fluorobenzoyl)benzoic acid aredescribed.